Arca Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABIO Nasdaq 8731 http://arcabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arca Biopharma Inc

James Flynn Joins ARCA biopharma Board of Directors - Dec 19th, 2022 9:05 pm
One ARCA biopharma, Inc. (NASDAQ:ABIO) insider upped their stake by 5,155% in the previous year - Nov 14th, 2022 2:24 pm
ARCA biopharma Announces Third Quarter 2022 Financial Results - Oct 28th, 2022 8:15 pm
ARCA biopharma Announces Second Quarter 2022 Financial Results - Aug 2nd, 2022 8:15 pm
Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Deliver On Growth Plans? - Jul 18th, 2022 10:14 am
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors - Jun 21st, 2022 8:05 pm
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review - May 5th, 2022 8:15 pm
ARCA biopharma Announces First Quarter 2022 Financial Results - May 2nd, 2022 8:15 pm
ARCA biopharma Establishes Special Committee of the Board of Directors - Apr 18th, 2022 8:30 pm
Albioma : Governance changes - Apr 5th, 2022 5:35 am
ARCA biopharma's Tissue Factor Inhibitor Disappoints In Mid-Stage COVID-19 Study - Apr 1st, 2022 11:09 am
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial - Mar 31st, 2022 8:15 pm
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update - Mar 14th, 2022 8:15 pm
Battalion Oil Corporation Announces Fourth Quarter and Full Year 2021 Financial and Operating Results - Mar 7th, 2022 9:30 pm
We're Keeping An Eye On ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate - Feb 8th, 2022 9:21 am